Format

Send to

Choose Destination
Biol Psychiatry. 1987 May;22(5):657-9.

A controlled trial of methylene blue in severe depressive illness.

Abstract

Methylene blue, 15 mg/day, was compared with placebo in treatment of severe depressive illness. The 3-week trial was designed to avoid bias by placebo response and also to avoid observer bias. Improvement in patients receiving methylene blue was significantly greater than in those receiving placebo. Methylene blue at a dose of 15 mg/day appears to be a potent antidepressant, and further clinical evaluation is essential.

PMID:
3555627
DOI:
10.1016/0006-3223(87)90194-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center